26518-73-0

Upstream product

• 5466-88-6 3,4-dihydro-3-oxo-2H-1,4-benzoxazine 
• 65-85-0 benzoic acid 

Downstream Products

• 901114-03-2 ethyl 2-ethoxy-3-[4-(2-{6-[(hydroxyimino)(phenyl)methyl]-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl}ethoxy)phenyl]propanoate 
• 901114-00-9 ethyl 2-ethoxy-3-[4-(2-{6-[(methoxyimino)(phenyl)methyl]-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl}ethoxy)phenyl]propanoate 
• 901113-96-0 2-ethoxy-3-[4-(2-{6-[(hydroxyimino)(phenyl)methyl]-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl}ethoxy)phenyl]propanoic acid 
• 901113-97-1 2-ethoxy-3-[4-(2-{6-[(methoxyimino)(phenyl)methyl]-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl}ethoxy)phenyl]propanoic acid 

Relevant academic research and scientific papers

Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them.

Compounds of formula (I): wherein: X represents an oxygen atom or a sulphur atom,R1, R2, R3 and R4 are as defined in the description,A represents an alkylene chain as defined in the description, andB represents

Aromatase inhibitor compounds and uses thereof

The invention concerns the use of a compound of formula (I) inhibitor of aromatase for the preparation of a pharmaceutical formulation intended for treatment of cancer or psoriasis. It equally relates to compounds of formula (I), notably for their use as active ingredients of a medication.